Printer Friendly

Browse Hemophilia topic

Drug therapy subtopic

Articles

1-54 out of 54 article(s)
Title Author Type Date Words
The Service On The Implementation Of Organizational Measures Related To The Provision Of Persons With Drugs Intended For The Treatment Of Patients With Hemophilia, Cystic Fibrosis, Pituitary Nanism, Gaucher Disease, Lymphoid, Hematopoietic And Related Tis. Jul 13, 2019 168
Provision Of Services For Acceptance, Storage, Delivery To Pharmacies And Delivery Of Drugs Intended For The Treatment Of Patients With Hemophilia, Cystic Fibrosis, Pituitary Nanism, Gaucher Disease, Lymphoid Neoplasms, Hematopoietic And Related Tissues,. Jul 12, 2019 148
Catalyst Biosciences receives orphan drug desgination for MarzAA in EU. Apr 1, 2019 202
19/08-1 Drugs Affecting Blood Formation And Blood (coagulation Factor Viii) For Patients Under The Age Of 18 Years. Mar 26, 2019 168
Germany : Bayer receives US approval for modern hemophilia A treatment Jivi with a step-wise prophylaxis dosing regimen. Sep 5, 2018 287
Bayer passes US FDA's approval for Jivi for the routine prophylactic treatment of hemophilia A. Sep 3, 2018 327
Bayer passes US FDA's approval for Jivi for the routine prophylactic treatment of hemophilia A. Sep 3, 2018 331
Bayer wins US FDA approval for Jivi for the routine prophylactic treatment of haemophilia A patients. Aug 31, 2018 299
Bayer wins US FDA approval for Jivi for the routine prophylactic treatment of haemophilia A patients. Aug 31, 2018 295
Provision Of Bypassing Agents For The Treatment Of Haemophilia With Inhibitors. May 18, 2018 103
Implementation Of Organizational Measures To Provide Citizens With Medicines Intended For The Treatment Of Patients With Malignant Neoplasms Of Lymphoid, Hematopoietic And Related Tissues, Hemophilia, Cystic Fibrosis, Pituitary Abscess, Gaucher Disease, M. Apr 1, 2018 167
Itb 56-2017-undp-ukr Procurement Of Medicines For Treatment Of Adults With Hemophilia And Children With Hemophilia A Or B Or Willebrand Disease And Medicines For Emergency Medical Care In Case Of Bleeding. Feb 19, 2018 106
Medicines For National Programs Ap - Ati, Treatment Of Rare Diseases - Sidpu, Diabetes, Dialysis, Treatment Of Haemophilia, Prophylaxis Of Rh Insomnia Syndrome ( romania-satu Mare: Medicinal Products For The Blood And Blood-forming Organs nd ). Dec 23, 2017 277
FDA Grants Orphan Drug Designation for TRM-201 (rofecoxib) for the Treatment of Hemophilic Arthropathy. Nov 22, 2017 513
Swedish Orphan Biovitrum AB wins the Saudi Food & Drug Authority's approval for Alprolix for the treatment of haemophilia B. Oct 25, 2017 337
Swedish Orphan Biovitrum AB wins the Saudi Food & Drug Authority's approval for Alprolix for the treatment of haemophilia B. Oct 25, 2017 333
Shire files investigational new drug application for SHP654 with US FDA. Jul 10, 2017 203
Shire files investigational new drug application for SHP654 with US FDA. Jul 10, 2017 199
FDA Accepts Bioverativ Investigational New Drug Application for BIVV001 to Treat Hemophilia A. Jun 13, 2017 287
Denmark : FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia. Jun 2, 2017 262
Novo Nordisk announces US FDA approval of REBINYN. Jun 1, 2017 159
Novo Nordisk announces US FDA approval of REBINYN. Jun 1, 2017 155
United States : Sangamo Receives Fast Track Designation From The FDA For SB-525 Investigational Hemophilia A Gene Therapy. May 22, 2017 249
Kazakhstan pharmaceutical complex to become producer of cancer drugs. Apr 13, 2017 193
Kazakhstan pharmaceutical complex to become producer of cancer drugs. Apr 13, 2017 189
China updates drugs included on its basic medical insurance scheme. Feb 23, 2017 249
China updates drugs included on its basic medical insurance scheme. Feb 23, 2017 245
Shire plc wins US FDA's approval for ADYNOVATE for twice-weekly dosing schedule for the treatment of hemophilia A in pediatric patients. Dec 28, 2016 322
Shire plc wins US FDA's approval for ADYNOVATE for twice-weekly dosing schedule for the treatment of hemophilia A in pediatric patients. Dec 28, 2016 318
BioMarin Pharmaceutical wins EC's orphan drug designation for BMN 270 for treating hemophilia A. Mar 25, 2016 256
BioMarin Pharmaceutical wins EC's orphan drug designation for BMN 270 for treating hemophilia A. Mar 25, 2016 260
Bayer receives US FDA approval for KOVALTRY haemophilia trreatment. Mar 18, 2016 142
Bayer receives US FDA approval for KOVALTRY haemophilia trreatment. Mar 18, 2016 138
Baxalta Incorporated unveils ADYNOVATE twice-weekly dosing schedule for treating hemophilia A. Dec 1, 2015 220
Baxalta Incorporated unveils ADYNOVATE twice-weekly dosing schedule for treating hemophilia A. Dec 1, 2015 216
Supply Drugs for Hospital and Er, and Related Medications National Cancer Program and the National Hemophilia Program. Dec 6, 2014 299
Baxter International. Nov 1, 2014 190
Baxter's FEIBA receives US FDA approval for FEIBA for prophylactic treatment of haemophilia patients with inhibitors. Dec 20, 2013 164
Baxter's FEIBA receives US FDA approval for FEIBA for prophylactic treatment of haemophilia patients with inhibitors. Dec 20, 2013 160
United States : ORPHAN DRUG designation for ALN-AT3. Aug 22, 2013 266
Biogen Idec's BLA for first long-lasting Factor VIII therapy ELOCTATE for haemophilia A accepted by US FDA. May 14, 2013 274
Biogen Idec's BLA for first long-lasting Factor VIII therapy ELOCTATE for haemophilia A accepted by US FDA. May 14, 2013 270
Acquired Factor VIII inhibitors: three cases / Edinsel Faktor VIII ihibitorleri: Uc Olgu. Kyaw, Tay Za; Jayaranee, S.; Ping, Chong Bee; Min Chin, Edmund Fui Case study Mar 1, 2013 3560
AMT's hemophilia B gene therapy gets FDA Orphan Drug status. Jan 4, 2012 172
-Jyske Bank lifts Novo Nordisk to "strong buy" on haemophilia drugs potential. Nov 25, 2011 225
-Jyske Bank lifts Novo Nordisk to "strong buy" on haemophilia drugs potential. Nov 25, 2011 227
-EU clears pediatric trial plan for Sobi haemophilia B drug. May 9, 2011 180
-EU clears pediatric trial plan for Sobi haemophilia B drug. May 9, 2011 181
-Swedish Orphan Biovitrum says haemophilia A drug gets orphan status in USA. Dec 23, 2010 238
-Swedish Orphan Biovitrum says haemophilia A drug gets orphan status in USA. Dec 23, 2010 240
Swedish Orphan Biovitrum's rFVIIIFc for Haemophilia A receives Orphan Drug Designation in the US. Dec 23, 2010 197
Wyeth joins forces with Nautilus. Feb 19, 2007 319
Avigen granted broad hemophilia A gene therapy patent. May 1, 2001 907
American Home and Targeted Genetics establish partnership for B-domain deleted factor VIII hemophilia gene Therapy. Brief Article Nov 1, 2000 572

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters